Previous Close | 16.42 |
Open | 16.75 |
Bid | 16.10 x 800 |
Ask | 16.25 x 800 |
Day's Range | 15.96 - 17.00 |
52 Week Range | 6.46 - 35.22 |
Volume | |
Avg. Volume | 3,807,798 |
Market Cap | 2.538B |
Beta (5Y Monthly) | 2.32 |
PE Ratio (TTM) | 53.97 |
EPS (TTM) | 0.30 |
Earnings Date | Jul 30, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 32.29 |
TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2024 Earnings Call Transcript May 2, 2024 TG Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the TG Therapeutics Conference Call and Webcast. At this time all participants are […]
TG Therapeutics, Inc. ( NASDAQ:TGTX ) shareholders will have a reason to smile today, with the analysts making...
TG Therapeutics ( NASDAQ:TGTX ) First Quarter 2024 Results Key Financial Results Revenue: US$63.5m (up by US$55.7m from...